Related Experiment Video

Updated: Jun 1, 2026

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis

Robert C Bast, David R Spriggs

    Gynecologic Oncology
    |May 24, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
    05:42

    An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

    Published on: January 26, 2024

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
    11:37

    In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

    Published on: February 18, 2015

    An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
    05:42

    An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

    Published on: January 26, 2024

    Related Concept Videos

    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...

    Articles linked to this work by shared authors, journal, and citation graph.

    Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer.

    Cancers·2026

    Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers.

    Signal transduction and targeted therapy·2025

    DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors.

    iScience·2025

    Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancers.

    Clinical proteomics·2025

    DIRAS3 Inhibits Ovarian Cancer Cell Growth by Blocking the Fibronectin-Mediated Integrin β1/FAK/AKT Signaling Pathway.

    Cells·2025

    GlycoKnow Ovarian: a Glycoprotein-based, Serum Diagnostic to Distinguish Ovarian Cancers from Benign Pelvic Masses.

    medRxiv : the preprint server for health sciences·2025

    Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201.

    Gynecologic oncology·2026

    Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.

    Gynecologic oncology·2026

    Planning and feasibility of phase III surgical trials in gynecologic oncology.

    Gynecologic oncology·2026

    Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

    Gynecologic oncology·2026

    Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

    Gynecologic oncology·2026

    Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis.

    Gynecologic oncology·2026

    Individualized breast cancer survival prediction in clinical practice: a SEER-derived interactive web tool integrating molecular and anatomical factors.

    Journal of public health (Oxford, England)·2026

    A Greek Real-World Experience With the Implementation of the EndoPredict Gene Signature in a Cohort of Pre-menopausal and Post-menopausal Patients With ER+/HER2- Breast Cancer.

    Cureus·2026

    A Myeloid-Specific Endogenous TRP1-CAR Knock-in Mouse Model for Melanoma-Targeted Immunotherapy.

    ImmunoTargets and therapy·2026

    Clinicopathological Features and Statistical Associations in Squamous Cell Carcinoma of the Lip.

    Current health sciences journal·2026

    Sex-Specific Predictive Value of Obesity-Related Indicators for Diabetic Kidney Disease in Type 2 Diabetes Mellitus.

    Diabetes, metabolic syndrome and obesity : targets and therapy·2026

    Prognostic Value of FST and Relevance to Immune Infiltration in Head and Neck Squamous Cell Carcinoma.

    World journal of otorhinolaryngology - head and neck surgery·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us